Signal Point Clinical Research is a clinical research site located in Middletown, Ohio, United States 45042.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Signal Point Clinical Research has participated in 2 clinical trials.
Therapeutic areas: Tumors, Patients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LEC.
Sponsors: Mateon Therapeutics, Eisai Inc..
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Signal Point Clinical Research has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Signal Point Clinical Research has 2 clinical trials on record. Their work covers Tumors, Patients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LEC.
Signal Point Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.